Nadim Ahmed, President and CEO at Cullinan Oncology, Inc. (CGEM), bought 8,090 shares at $12.40 ($100K) on 2022-06-06, disclosed to the SEC on 2022-06-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CGEM | SELL | 2025-12-29 | $199K | — | Filing → |
| CGEM | SELL | 2025-02-27 | $214K | — | Filing → |
| CGEM | SELL | 2024-12-27 | $100K | — | Filing → |